NO20030656D0 - Pyruvat:NADP + oksidoreduktase og anvendelser derav - Google Patents

Pyruvat:NADP + oksidoreduktase og anvendelser derav

Info

Publication number
NO20030656D0
NO20030656D0 NO20030656A NO20030656A NO20030656D0 NO 20030656 D0 NO20030656 D0 NO 20030656D0 NO 20030656 A NO20030656 A NO 20030656A NO 20030656 A NO20030656 A NO 20030656A NO 20030656 D0 NO20030656 D0 NO 20030656D0
Authority
NO
Norway
Prior art keywords
nadp
oxidoreductase
pyruvate
applications
Prior art date
Application number
NO20030656A
Other languages
English (en)
Other versions
NO20030656L (no
Inventor
Petra Cirpus
Jens Lerchl
William Martin
Carmen Rotte
Original Assignee
Basf Plant Science Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Plant Science Gmbh filed Critical Basf Plant Science Gmbh
Publication of NO20030656D0 publication Critical patent/NO20030656D0/no
Publication of NO20030656L publication Critical patent/NO20030656L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030656A 2000-08-17 2003-02-10 Pyruvat:NADP + oksidoreduktase og anvendelser derav NO20030656L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117730A EP1182259A1 (en) 2000-08-17 2000-08-17 Pyruvate:NADP+ oxidoreductase and uses thereof
PCT/EP2001/009317 WO2002014522A1 (en) 2000-08-17 2001-08-11 Pyruvate:nadp+ oxidoreductase and uses thereof

Publications (2)

Publication Number Publication Date
NO20030656D0 true NO20030656D0 (no) 2003-02-10
NO20030656L NO20030656L (no) 2003-04-14

Family

ID=8169561

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030656A NO20030656L (no) 2000-08-17 2003-02-10 Pyruvat:NADP + oksidoreduktase og anvendelser derav

Country Status (10)

Country Link
US (1) US20040101865A1 (no)
EP (2) EP1182259A1 (no)
JP (1) JP2004515223A (no)
AR (1) AR030354A1 (no)
AU (2) AU2001284009B2 (no)
BR (1) BR0113309A (no)
CA (1) CA2419020A1 (no)
IL (1) IL154073A0 (no)
NO (1) NO20030656L (no)
WO (1) WO2002014522A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095636A2 (en) * 2004-03-24 2005-10-13 Aveo Pharmaceuticals, Inc. Methods for measuring enzyme activities in cells, blood, tumors and tissues
PT2132318E (pt) * 2007-03-16 2012-11-28 Univ California Composições e métodos para a redução dos níveis de h2s em bebidas fermentadas
EP2546349A1 (en) * 2007-04-03 2013-01-16 Tabletop Energy Methods for transforming eukaryotic algae
WO2009006386A2 (en) * 2007-06-29 2009-01-08 The Regents Of The University Of California Host cells and methods for producing isoprenyl alkanoates
JP2010263790A (ja) 2007-09-04 2010-11-25 Ajinomoto Co Inc アミノ酸生産微生物及びアミノ酸の製造法
EP2192170B1 (en) * 2007-09-04 2017-02-15 Ajinomoto Co., Inc. Amino acid-producing microorganism and method of producing amino acid
RU2395579C2 (ru) 2007-12-21 2010-07-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТЫ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ, ПРИНАДЛЕЖАЩЕЙ К РОДУ Escherichia
CZ2012571A3 (cs) 2012-08-27 2013-12-11 Vysoké ucení technické v Brne Zpusob produkce polyhydroxyalkanoátu (PHA) na olejovém substrátu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955329A (en) * 1995-05-15 1999-09-21 Calgene, Inc. Engineering plant thioesterases for altered substrate specificity
AU8473198A (en) * 1997-06-30 1999-01-19 Curators Of The University Of Missouri, The Use of dna encoding plastid pyruvate dehydrogenase and branched chain oxoa cid dehydrogenase components to enhance polyhydroxyalkanoate biosynthesis in p lants
TR200100705T2 (tr) * 1998-06-26 2001-10-22 Iowa State University Research Foundation, Inc. Bitkilerde enzim ve asetil'in değiştirilmesi için yöntemler.
WO2000011199A1 (en) * 1998-08-20 2000-03-02 Pioneer Hi-Bred International, Inc. COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT

Also Published As

Publication number Publication date
EP1182259A1 (en) 2002-02-27
JP2004515223A (ja) 2004-05-27
BR0113309A (pt) 2003-07-01
US20040101865A1 (en) 2004-05-27
NO20030656L (no) 2003-04-14
CA2419020A1 (en) 2002-02-21
EP1311694A1 (en) 2003-05-21
AU2001284009B8 (en) 2002-02-25
AU2001284009B2 (en) 2007-07-26
IL154073A0 (en) 2003-07-31
AU8400901A (en) 2002-02-25
WO2002014522A1 (en) 2002-02-21
AR030354A1 (es) 2003-08-20

Similar Documents

Publication Publication Date Title
NO20025656L (no) Opplöselige CTLA4 mutantmolekyler og anvendelser derav
NO20040865L (no) Friksjon reduserende sammensetning og metode
NO20052469D0 (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
DK1549736T3 (da) Pentose-sukker-fermenterende zymomonas-stamme og anvendelser deraf
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
DE60112893D1 (de) Quetschventil
EP1466979A4 (en) LYSYLE OXYDASES OF FUNGIC ORIGIN
DK1322597T3 (da) Fremgangsmåde og intermediære
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
DE60239456D1 (de) Amplifizierungsverfahren
NO20030656D0 (no) Pyruvat:NADP + oksidoreduktase og anvendelser derav
DE60236621D1 (de) Smedium
GB0230238D0 (en) Combined exponential and linear amplification
EP1700919A4 (en) BIOSENSOR HAVING A SOIL MICROORGANISM CONTAINED WITHIN THE BIOSPER AND USE THEREOF
DK1456377T3 (da) Syn3-sammensætninger og fremgangsmåder
NO20014946D0 (no) Strukturerte flerbrukspakninger og deres anvendelse
DE60142521D1 (de) Aerobes fermentationsverfahren
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
NO20025135L (no) Antihypertensive midler og anvendelse
BRPI0307722A2 (pt) microorganismo envolvido
FR2809105B1 (fr) Amorces d'amplification modifiees et leurs utilisations
DK200100312U3 (da) Bålplads i metal
UA4444S (uk) Інформаційно-рекламний комплект
NO20033636L (no) Levothyroxin sammensetninger og fremgangsmåter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application